If past performance guaranteed future success, Vertex Pharmaceuticals (NASDAQ: VRTX) would be one of the best biotech stocks to invest in. The drugmaker has consistently outperformed the broader market in the past decade. However, investors are more interested in what will happen from here on out -- and Vertex's strong track record unfortunately is still no guarantee of what could lay ahead.

So is it too late to invest in this market beater, or does Vertex Pharmaceuticals still have what it takes to deliver outsize returns? Let's find out.

Continue reading

Source Fool.com